Our findings provide insights into the mechanisms underlying the actions of FGF21 on neurodegeneration and brain energy metabolism, and suggest that FGF21 may have potential therapeutic value in the treatment of AD and other neurodegenerative diseases. The gene discussed is FGF21; the disease is neurodegenerative disease.